Sander Dale A. 4
4 · Humacyte, Inc. · Filed Aug 29, 2024
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Sander Dale A.
CFO and Chief Corp. Deve. Off.
Transactions
- Exercise/Conversion
Common Stock
2024-08-27$2.56/sh+39,389$100,836→ 41,389 total - Exercise/Conversion
Stock Options (right to buy)
2024-08-27−39,389→ 0 totalExercise: $2.56From: 2018-09-01Exp: 2025-09-01→ Common Stock (39,389 underlying) - Sale
Common Stock
2024-08-27$6.68/sh−39,389$263,119→ 2,000 total
Holdings
- 20,600(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $6.67 to $6.725. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.